Breast cancer prognosis and treatment mostly relies on a few markers such as the estrogen receptor (ER), progesterone receptor (PgR), the human epidermal growth factor receptor 2 (HER2/neu) and tumor stage. This evidence concerns the gene ERBB2 and breast carcinoma.